Literature DB >> 30154087

2018 update of the EULAR recommendations for the management of hand osteoarthritis.

Margreet Kloppenburg1,2, Féline Pb Kroon1, Francisco J Blanco3, Michael Doherty4, Krysia S Dziedzic5, Elsie Greibrokk6, Ida K Haugen6, Gabriel Herrero-Beaumont7, Helgi Jonsson8, Ingvild Kjeken6, Emmanuel Maheu9, Roberta Ramonda10, Marco Jpf Ritt11, Wilma Smeets1,2,3, Josef S Smolen12, Tanja A Stamm13, Zoltan Szekanecz14, Ruth Wittoek15, Loreto Carmona16.   

Abstract

Since publication of the European League Against Rheumatism (EULAR) recommendations for management of hand osteoarthritis (OA) in 2007 new evidence has emerged. The aim was to update these recommendations. EULAR standardised operating procedures were followed. A systematic literature review was performed, collecting the evidence regarding all non-pharmacological, pharmacological and surgical treatment options for hand OA published to date. Based on the evidence and expert opinion from an international task force of 19 physicians, healthcare professionals and patients from 10 European countries formulated overarching principles and recommendations. Level of evidence, grade of recommendation and level of agreement were allocated to each statement. Five overarching principles and 10 recommendations were agreed on. The overarching principles cover treatment goals, information provision, individualisation of treatment, shared decision-making and the need to consider multidisciplinary and multimodal (non-pharmacological, pharmacological, surgical) treatment approaches. Recommendations 1-3 cover different non-pharmacological treatment options (education, assistive devices, exercises and orthoses). Recommendations 4-8 describe the role of different pharmacological treatments, including topical treatments (preferred over systemic treatments, topical non-steroidal anti-inflammatory drugs (NSAIDs) being first-line choice), oral analgesics (particularly NSAIDs to be considered for symptom relief for a limited duration), chondroitin sulfate (for symptom relief), intra-articular glucocorticoids (generally not recommended, consider for painful interphalangeal OA) and conventional/biological disease-modifying antirheumatic drugs (discouraged). Considerations for surgery are described in recommendation 9. The last recommendation relates to follow-up. The presented EULAR recommendations provide up-to-date guidance on the management of hand OA, based on expert opinion and research evidence. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  hand osteoarthritis; treatment

Mesh:

Substances:

Year:  2018        PMID: 30154087     DOI: 10.1136/annrheumdis-2018-213826

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  58 in total

Review 1.  Core and adjunctive interventions for osteoarthritis: efficacy and models for implementation.

Authors:  Jocelyn L Bowden; David J Hunter; Leticia A Deveza; Vicky Duong; Krysia S Dziedzic; Kelli D Allen; Ping-Keung Chan; Jillian P Eyles
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

2.  Substantial Increase in the Incidence of Surgery for Osteoarthritis of the Base of the Thumb Between 1997 and 2019 in Finland.

Authors:  Meri Myohanen; Eero Waris; Panu H Nordback; Simo Mattila; Samuli Aspinen
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Efficacy and safety of corticosteroid in the treatment of hand osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Xing Wang; Peng Wang; Andrew Faramand; Xi Zha; Yu Zhang; Weelic Chong; Yang Hai; Fang Fang
Journal:  Clin Rheumatol       Date:  2022-01-29       Impact factor: 2.980

4.  The effect of index finger distal interphalangeal joint arthrodesis on muscle forces and adjacent joint contact pressures.

Authors:  Thomas Valerio; Benjamin Goislard de Monsabert; Barthélémy Faudot; Jean-Baptiste De Villeneuve Bargemon; Charlotte Jaloux; Jean-Louis Milan; Laurent Vigouroux
Journal:  Med Biol Eng Comput       Date:  2022-07-02       Impact factor: 3.079

5.  Impact of thumb osteoarthritis on pain, function, and quality of life: a comparative study between erosive and non-erosive hand osteoarthritis.

Authors:  Sara Tenti; Fabio Ferretti; Roberto Gusinu; Ines Gallo; Stefano Giannotti; Andrea Pozza; Antonella Fioravanti; Anna Coluccia
Journal:  Clin Rheumatol       Date:  2020-02-22       Impact factor: 2.980

6.  Familial Clustering of Erosive Hand Osteoarthritis in a Large Statewide Cohort.

Authors:  Nikolas H Kazmers; Huong D Meeks; Kendra A Novak; Zhe Yu; Gail L Fulde; Joy L Thomas; Tyler Barker; Michael J Jurynec
Journal:  Arthritis Rheumatol       Date:  2021-01-29       Impact factor: 10.995

Review 7.  Erosive hand osteoarthritis: latest findings and outlook.

Authors:  Marta Favero; Elisa Belluzzi; Augusta Ortolan; Mariagrazia Lorenzin; Francesca Oliviero; Andrea Doria; Carla R Scanzello; Roberta Ramonda
Journal:  Nat Rev Rheumatol       Date:  2022-02-01       Impact factor: 20.543

8.  The Long-term Results of Proximal Interphalangeal Joint Arthroplasty of the Osteoarthritic Index Finger.

Authors:  Tomos Richards; Laura Ingham; Ian Russell; David Newington
Journal:  Hand (N Y)       Date:  2020-05-26

9.  Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.

Authors:  Claudia Kedor; Jacqueline Detert; Rolf Rau; Siegfried Wassenberg; Joachim Listing; Pascal Klaus; Tanja Braun; Walter Hermann; Stefan Markus Weiner; Frank Buttgereit; Gerd R Burmester
Journal:  RMD Open       Date:  2021-07

10.  Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial.

Authors:  Ioana R Marian; Megan Goff; Jennifer A E Williams; Malvika Gulati; Mae Chester-Jones; Anne Francis; Marion Watson; Tonia L Vincent; Sue Woollacott; Charles Mackworth-Young; Victoria Glover; Dominic Furniss; Matthew Gardiner; Sarah E Lamb; Katy Vincent; Vicki S Barber; Joanna Black; Susan J Dutton; Fiona E Watt
Journal:  Pilot Feasibility Stud       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.